β-Blockers in Chronic Obstructive Pulmonary Disease-Walking the Tightrope

Affiliations

¹ Division of Pulmonary & Critical Care, University of Michigan, Ann Arbor.
² Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama, Birmingham.

Editorial

MeiLan K Han et al. JAMA. 2024.

. 2024 Aug 13;332(6):458-459.

doi: 10.1001/jama.2024.8743.

¹ Division of Pulmonary & Critical Care, University of Michigan, Ann Arbor.
² Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama, Birmingham.

No abstract available

Comment on

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial.
Devereux G, Cotton S, Nath M, McMeekin N, Campbell K, Chaudhuri R, Choudhury G, De Soyza A, Fielding S, Gompertz S, Haughney J, Lee AJ, MacLennan G, Morice A, Norrie J, Price D, Short P, Vestbo J, Walker P, Wedzicha J, Wilson A, Wu O, Lipworth BJ. Devereux G, et al. JAMA. 2024 Aug 13;332(6):462-470. doi: 10.1001/jama.2024.8771. JAMA. 2024. PMID: 38762800 Free PMC article. Clinical Trial.